Skip to content

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Construction and Psychometric Properties of the Therapeutic Adherence Scale for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06477302
Acronym
STA-RR-LC
Enrollment
281
Registered
2024-06-27
Start date
2023-06-23
Completion date
2027-06-23
Last updated
2025-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

pulmonary rehabilitation, therapeutic adherence, Lung Cancer

Brief summary

The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis. The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation? The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.

Detailed description

For the recruitment patients with lung cancer diagnosis that arrive at the Respiratory Rehabilitation service will be asked if they are willing to participate and fill out the STA. It will be explained to them as clearly as possible the objective, procedure, risks and benefits of the study and a copy of the Informed Consent will be provided. Lung cancer patients attending the Pulmonary Rehabilitation service will be approached and a verbal explanation of the study will be given.

Interventions

BEHAVIORALScale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer (STA-RR-LC)

Patients will be given a measurement instrument to determine the level of therapeutic adherence.

Sponsors

Instituto Nacional de Cancerologia de Mexico
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with lung cancer (SCLC and NSCLC). * Over 18 years of age. * Voluntary participation by understanding and accepting the informed consent letter. * Patients undergoing Respiratory Rehabilitation treatment with one month assessment and follow-up. * Patients in active medical treatment. * Any clinical stage. * Karnofsky Index ≥ 70.

Exclusion criteria

* Severe hearing or visual problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the clinical record file). * Severe psychiatric conditions (schizophrenia or psychotic disorders) and/or addiction to any psychoactive substance (this will be identified as reported in the INCanet file). * Attentional or memory problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the INCanet file).

Design outcomes

Primary

MeasureTime frameDescription
Contruction of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC)the STA-RR-LC will be applied for one time and as soon as the patient has completed one month attending the Respiratory Rehabilitation Service.The validity of the construction is carried out with an exploratory factor analysis using the Maximum Likelihood extraction method and the oblique rotation (direct Oblimin). Confiability is determitated using the Alpha of Cronbach coefficient.

Secondary

MeasureTime frameDescription
Verify the concurrent validity of the instrumentthe STA-RR-LC will be applied one time, as soon as the patient has completed one month attending the Respiratory Rehabilitation ServiceIt will be verified using the current scores of the European Organisation for Research and Treatment of Cancer, specifically the Module of Lung Cancer (EORTC-QLQ-LC29).

Countries

Mexico

Contacts

Primary ContactOscar G Arrieta, MD
ogar@unam.mx+52 55 5628 0400
Backup ContactJosue R Alcantar-Correa, MD
richard.alcantar.incan@gmail.com+52 55 5628 0400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026